Development and analysis of an in vivo-compatible metabolic network of Mycobacterium tuberculosis

BMC Systems Biology

Volumn 4, Issue , 2010, Pages

  Fang, Xin ^a   Wallqvist, Anders ^a   Reifman, Jaques ^a  

^a U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOBACTERIUM TUBERCULOSIS;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; DATA MINING; GENE DELETION; GENETICS; GROWTH, DEVELOPMENT AND AGING; MACROPHAGE; METABOLISM; METHODOLOGY; MICROBIOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; REPRODUCIBILITY; SYSTEMS BIOLOGY; TUBERCULOSIS;

ANIMALS; DATA MINING; MACROPHAGES; METABOLIC NETWORKS AND PATHWAYS; MICE; MODELS, BIOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS; SEQUENCE DELETION; SYSTEMS BIOLOGY; TUBERCULOSIS;

EID: 78549238928     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-4-160     Document Type: Article

References (82)

1. Gillespie SH. Tuberculosis: evolution in millennia and minutes. Biochem Soc Trans 2007, 35:1317-1320. 10.1042/BST0351317, 17956341.
2. WHO WHO Report 2008: Global tuberculosis control - surveillance, planning, financing. 2008, WHO.
3. van den Boogaard J, Kibiki GS, Kisanga ER, Boeree MJ, Aarnoutse RE. New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development. Antimicrob Agents Chemother 2009, 53:849-862. 10.1128/AAC.00749-08, 2650526, 19075046.
4. Young DB, Perkins MD, Duncan K, Barry CE. Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest 2008, 118:1255-1265. 10.1172/JCI34614, 2276805, 18382738.
5. Anishetty S, Pulimi M, Pennathur G. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis. Comput Biol Chem 2005, 29:368-378. 10.1016/j.compbiolchem.2005.07.001, 16213791.
6. Mdluli K, Spigelman M. Novel targets for tuberculosis drug discovery. Curr Opin Pharmacol 2006, 6:459-467. 10.1016/j.coph.2006.06.004, 16904376.
7. Boshoff HI, Barry CE. Tuberculosis - metabolism and respiration in the absence of growth. Nat Rev Microbiol 2005, 3:70-80. 10.1038/nrmicro1065, 15608701.
8. Munoz-Elias EJ, McKinney JD. Carbon metabolism of intracellular bacteria. Cell Microbiol 2006, 8:10-22. 10.1111/j.1462-5822.2005.00648.x, 16367862.
9. Scortti M, Lacharme-Lora L, Wagner M, Chico-Calero I, Losito P, Vazquez-Boland JA. Coexpression of virulence and fosfomycin susceptibility in Listeria: molecular basis of an antimicrobial in vitro-in vivo paradox. Nat Med 2006, 12:515-517. 10.1038/nm1396, 16633349.
10. Smith H. Questions about the behaviour of bacterial pathogens in vivo. Philos Trans R Soc Lond B Biol Sci 2000, 355:551-564. 10.1098/rstb.2000.0597, 1692770, 10874729.
11. Feist AM, Herrgard MJ, Thiele I, Reed JL, Palsson BO. Reconstruction of biochemical networks in microorganisms. Nat Rev Microbiol 2009, 7:129-143.
12. Breitling R, Vitkup D, Barrett MP. New surveyor tools for charting microbial metabolic maps. Nat Rev Microbiol 2008, 6:156-161. 10.1038/nrmicro1797, 18026122.
13. Feist AM, Henry CS, Reed JL, Krummenacker M, Joyce AR, Karp PD, Broadbelt LJ, Hatzimanikatis V, Palsson BO. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol Syst Biol 2007, 3:121. 10.1038/msb4100155, 1911197, 17593909.
14. Thiele I, Vo TD, Price ND, Palsson BO. Expanded metabolic reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an in silico genome-scale characterization of single- and double-deletion mutants. J Bacteriol 2005, 187:5818-5830. 10.1128/JB.187.16.5818-5830.2005, 1196094, 16077130.
15. Jamshidi N, Palsson BO. Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets. BMC Syst Biol 2007, 1:26. 10.1186/1752-0509-1-26, 1925256, 17555602.
16. Beste DJ, Hooper T, Stewart G, Bonde B, Avignone-Rossa C, Bushell ME, Wheeler P, Klamt S, Kierzek AM, McFadden J. GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism. Genome Biol 2007, 8:R89. 10.1186/gb-2007-8-5-r89, 1929162, 17521419.
17. Duarte NC, Herrgard MJ, Palsson BO. Reconstruction and validation of Saccharomyces cerevisiae iND750, a fully compartmentalized genome-scale metabolic model. Genome Res 2004, 14:1298-1309. 10.1101/gr.2250904, 442145, 15197165.
18. Yeh I, Hanekamp T, Tsoka S, Karp PD, Altman RB. Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery. Genome Res 2004, 14:917-924. 10.1101/gr.2050304, 479120, 15078855.
19. Chavali AK, Whittemore JD, Eddy JA, Williams KT, Papin JA. Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major. Mol Syst Biol 2008, 4:177. 10.1038/msb.2008.15, 2290936, 18364711.
20. Sheikh K, Forster J, Nielsen LK. Modeling hybridoma cell metabolism using a generic genome-scale metabolic model of Mus musculus. Biotechnol Prog 2005, 21:112-121. 10.1021/bp0498138, 15903248.
21. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srivas R, Palsson BO. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci USA 2007, 104:1777-1782. 10.1073/pnas.0610772104, 1794290, 17267599.
22. Systems Biology Research Group, University of California, San Diego Systems Biology Research Group, University of California, San Diego., http://gcrg.ucsd.edu/In_Silico_Organisms/Other_Organisms
23. Famili I, Forster J, Nielsen J, Palsson BO. Saccharomyces cerevisiae phenotypes can be predicted by using constraint-based analysis of a genome-scale reconstructed metabolic network. Proc Natl Acad Sci USA 2003, 100:13134-13139. 10.1073/pnas.2235812100, 263729, 14578455.
24. Raghunathan A, Reed J, Shin S, Palsson B, Daefler S. Constraint-based analysis of metabolic capacity of Salmonella typhimurium during host-pathogen interaction. BMC Syst Biol 2009, 3:38. 10.1186/1752-0509-3-38, 2678070, 19356237.
25. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393:537-544. 10.1038/31159, 9634230.
26. Fang X, Wallqvist A, Reifman J. A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis. BMC Syst Biol 2009, 3:92. 10.1186/1752-0509-3-92, 2759933, 19754970.
27. Boshoff HI, Barry CE. A low-carb diet for a high-octane pathogen. Nat Med 2005, 11:599-600. 10.1038/nm0605-599, 15937469.
28. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, Dolganov G, Efron B, Butcher PD, Nathan C, Schoolnik GK. Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment. J Exp Med 2003, 198:693-704. 10.1084/jem.20030846, 2194186, 12953091.
29. Talaat AM, Lyons R, Howard ST, Johnston SA. The temporal expression profile of Mycobacterium tuberculosis infection in mice. Proc Natl Acad Sci USA 2004, 101:4602-4607. 10.1073/pnas.0306023101, 384793, 15070764.
30. Colijn C, Brandes A, Zucker J, Lun DS, Weiner B, Farhat MR, Cheng TY, Moody DB, Murray M, Galagan JE. Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production. PLoS Comput Biol 2009, 5:e1000489. 10.1371/journal.pcbi.1000489, 2726785, 19714220.
31. Aly S, Wagner K, Keller C, Malm S, Malzan A, Brandau S, Bange FC, Ehlers S. Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected mice. J Pathol 2006, 210:298-305. 10.1002/path.2055, 17001607.
32. Munoz-Elias EJ, McKinney JD. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med 2005, 11:638-644. 10.1038/nm1252, 1464426, 15895072.
33. Hingley-Wilson SM, Sambandamurthy VK, Jacobs WR. Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis. Nat Immunol 2003, 4:949-955. 10.1038/ni981, 14515128.
34. Sassetti CM, Rubin EJ. Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci USA 2003, 100:12989-12994. 10.1073/pnas.2134250100, 240732, 14569030.
35. Sassetti CM, Boyd DH, Rubin EJ. Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 2003, 48:77-84. 10.1046/j.1365-2958.2003.03425.x, 12657046.
36. Murphy HN, Stewart GR, Mischenko VV, Apt AS, Harris R, McAlister MS, Driscoll PC, Young DB, Robertson BD. The OtsAB pathway is essential for trehalose biosynthesis in Mycobacterium tuberculosis. J Biol Chem 2005, 280:14524-14529. 10.1074/jbc.M414232200, 15703182.
37. Oh YK, Palsson BO, Park SM, Schilling CH, Mahadevan R. Genome-scale reconstruction of metabolic network in Bacillus subtilis based on high-throughput phenotyping and gene essentiality data. J Biol Chem 2007, 282:28791-28799. 10.1074/jbc.M703759200, 17573341.
38. Durot M, Le Fevre F, de Berardinis V, Kreimeyer A, Vallenet D, Combe C, Smidtas S, Salanoubat M, Weissenbach J, Schachter V. Iterative reconstruction of a global metabolic model of Acinetobacter baylyi ADP1 using high-throughput growth phenotype and gene essentiality data. BMC Syst Biol 2008, 2:85. 10.1186/1752-0509-2-85, 2606687, 18840283.
39. Kumar VS, Maranas CD. GrowMatch: an automated method for reconciling in silico/in vivo growth predictions. PLoS Comput Biol 2009, 5:e1000308. 10.1371/journal.pcbi.1000308, 2645679, 19282964.
40. Joyce AR, Palsson BO. Predicting gene essentiality using genome-scale in silico models. Methods Mol Biol 2008, 416:433-457. full_text, 18392986.
41. Price ND, Papin JA, Schilling CH, Palsson BO. Genome-scale microbial in silico models: the constraints-based approach. Trends Biotechnol 2003, 21:162-169. 10.1016/S0167-7799(03)00030-1, 12679064.
42. Becker SA, Feist AM, Mo ML, Hannum G, Palsson BO, Herrgard MJ. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox. Nat Protoc 2007, 2:727-738. 10.1038/nprot.2007.99, 17406635.
43. Caspi R, Foerster H, Fulcher CA, Hopkinson R, Ingraham J, Kaipa P, Krummenacker M, Paley S, Pick J, Rhee SY, et al. MetaCyc: a multiorganism database of metabolic pathways and enzymes. Nucleic Acids Res 2006, 34:D511-516. 10.1093/nar/gkj128, 1347490, 16381923.
44. Kanehisa M, Goto S, Hattori M, Aoki-Kinoshita KF, Itoh M, Kawashima S, Katayama T, Araki M, Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 2006, 34:D354-357. 10.1093/nar/gkj102, 1347464, 16381885.
45. Henry CS, Zinner JF, Cohoon MP, Stevens RL. iBsu1103: a new genome-scale metabolic model of Bacillus subtilis based on SEED annotations. Genome Biol 2009, 10:R69. 10.1186/gb-2009-10-6-r69, 2718503, 19555510.
46. Jones PA, Scott-Burden T. Activated macrophages digest the extracellular matrix proteins produced by cultured cells. Biochem Biophys Res Commun 1979, 86:71-77. 10.1016/0006-291X(79)90383-8, 435306.
47. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 1988, 27:8706-8711. 10.1021/bi00424a003, 3242600.
48. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, Sherman DR, Schoolnik GK. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 2003, 198:705-713. 10.1084/jem.20030205, 2194188, 12953092.
49. Baldi P, Brunak S, Chauvin Y, Andersen CA, Nielsen H. Assessing the accuracy of prediction algorithms for classification: an overview. Bioinformatics 2000, 16:412-424. 10.1093/bioinformatics/16.5.412, 10871264.
50. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993, 39:561-577.
51. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845. 10.2307/2531595, 3203132.
52. Timm J, Post FA, Bekker LG, Walther GB, Wainwright HC, Manganelli R, Chan WT, Tsenova L, Gold B, Smith I, et al. Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients. Proc Natl Acad Sci USA 2003, 100:14321-14326. 10.1073/pnas.2436197100, 283590, 14623960.
53. Dubnau E, Chan J, Mohan VP, Smith I. responses of mycobacterium tuberculosis to growth in the mouse lung. Infect Immun 2005, 73:3754-3757. 10.1128/IAI.73.6.3754-3757.2005, 1111836, 15908407.
54. Kendall SL, Rison SC, Movahedzadeh F, Frita R, Stoker NG. What do microarrays really tell us about M. tuberculosis?. Trends Microbiol 2004, 12:537-544. 10.1016/j.tim.2004.10.005, 15539113.
55. Jansen A, Yu J. Differential gene expression of pathogens inside infected hosts. Curr Opin Microbiol 2006, 9:138-142. 10.1016/j.mib.2006.01.003, 16459132.
56. Kondo E, Suzuki K, Kanai K, Yasuda T. Liposomes-mycobacteria incubation systems as a partial model of host-parasite interaction at cell membrane level. Jpn J Med Sci Biol 1985, 38:169-180.
57. Brinster S, Lamberet G, Staels B, Trieu-Cuot P, Gruss A, Poyart C. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature 2009, 458:83-86. 10.1038/nature07772, 19262672.
58. Morgunova E, Illarionov B, Sambaiah T, Haase I, Bacher A, Cushman M, Fischer M, Ladenstein R. Structural and thermodynamic insights into the binding mode of five novel inhibitors of lumazine synthase from Mycobacterium tuberculosis. FEBS J 2006, 273:4790-4804. 10.1111/j.1742-4658.2006.05481.x, 16984393.
59. Reche P, Perham RN. Structure and selectivity in post-translational modification: attaching the biotinyl-lysine and lipoyl-lysine swinging arms in multifunctional enzymes. EMBO J 1999, 18:2673-2682. 10.1093/emboj/18.10.2673, 1171349, 10329614.
60. De Clercq PJ. Biotin: a timeless challenge for total synthesis. Chem Rev 1997, 97:1755-1792. 10.1021/cr950073e, 11848892.
61. Awasthy D, Gaonkar S, Shandil RK, Yadav R, Bharath S, Marcel N, Subbulakshmi V, Sharma U. Inactivation of the ilvB1 gene in Mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice. Microbiology 2009, 155:2978-2987. 10.1099/mic.0.029884-0, 19542000.
62. Rousseau C, Winter N, Pivert E, Bordat Y, Neyrolles O, Ave P, Huerre M, Gicquel B, Jackson M. Production of phthiocerol dimycocerosates protects Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates produced by macrophages and modulates the early immune response to infection. Cell Microbiol 2004, 6:277-287. 10.1046/j.1462-5822.2004.00368.x, 14764111.
63. Malm S, Tiffert Y, Micklinghoff J, Schultze S, Joost I, Weber I, Horst S, Ackermann B, Schmidt M, Wohlleben W, et al. The roles of the nitrate reductase NarGHJI, the nitrite reductase NirBD and the response regulator GlnR in nitrate assimilation of Mycobacterium tuberculosis. Microbiology 2009, 155:1332-1339. 10.1099/mic.0.023275-0, 19332834.
64. De Voss JJ, Rutter K, Schroeder BG, Su H, Zhu Y, Barry CE. The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc Natl Acad Sci USA 2000, 97:1252-1257. 10.1073/pnas.97.3.1252, 15586, 10655517.
65. Youmans GP, Youmans AS. Studies on the metabolism of Mycobacterium tuberculosis. I. The effect of carbohydrates and alcohols on the growth of Mycobacterium tuberculosis var. hominis. J Bacteriol 1953, 65:92-95. 169466, 13022637.
66. Titgemeyer F, Amon J, Parche S, Mahfoud M, Bail J, Schlicht M, Rehm N, Hillmann D, Stephan J, Walter B, et al. A genomic view of sugar transport in Mycobacterium smegmatis and Mycobacterium tuberculosis. J Bacteriol 2007, 189:5903-5915. 10.1128/JB.00257-07, 1952047, 17557815.
67. Hu W, Sillaots S, Lemieux S, Davison J, Kauffman S, Breton A, Linteau A, Xin C, Bowman J, Becker J, et al. Essential gene identification and drug target prioritization in Aspergillus fumigatus. PLoS Pathog 2007, 3:e24. 10.1371/journal.ppat.0030024, 1817658, 17352532.
68. Harrison R, Papp B, Pal C, Oliver SG, Delneri D. Plasticity of genetic interactions in metabolic networks of yeast. Proc Natl Acad Sci USA 2007, 104:2307-2312. 10.1073/pnas.0607153104, 1892960, 17284612.
69. Deutscher D, Meilijson I, Kupiec M, Ruppin E. Multiple knockout analysis of genetic robustness in the yeast metabolic network. Nat Genet 2006, 38:993-998. 10.1038/ng1856, 16941010.
70. Le Meur N, Gentleman R. Modeling synthetic lethality. Genome Biol 2008, 9:R135. 10.1186/gb-2008-9-9-r135, 2592713, 18789146.
71. Suthers PF, Zomorrodi A, Maranas CD. Genome-scale gene/reaction essentiality and synthetic lethality analysis. Mol Syst Biol 2009, 5:301. 10.1038/msb.2009.56, 2736653, 19690570.
72. Sambandamurthy VK, Wang X, Chen B, Russell RG, Derrick S, Collins FM, Morris SL, Jacobs WR. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat Med 2002, 8:1171-1174. 10.1038/nm765, 12219086.
73. MacMicking JD, Taylor GA, McKinney JD. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 2003, 302:654-659. 10.1126/science.1088063, 14576437.
74. Vandal OH, Nathan CF, Ehrt S. Acid resistance in Mycobacterium tuberculosis. J Bacteriol 2009, 191:4714-4721. 10.1128/JB.00305-09, 2715723, 19465648.
75. Reyrat JM, Berthet FX, Gicquel B. The urease locus of Mycobacterium tuberculosis and its utilization for the demonstration of allelic exchange in Mycobacterium bovis bacillus Calmette-Guerin. Proc Natl Acad Sci USA 1995, 92:8768-8772. 10.1073/pnas.92.19.8768, 41048, 7568014.
76. Clemens DL, Lee BY, Horwitz MA. Purification, characterization, and genetic analysis of Mycobacterium tuberculosis urease, a potentially critical determinant of host-pathogen interaction. J Bacteriol 1995, 177:5644-5652. 177376, 7559354.
77. Gordon AH, Hart PD, Young MR. Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature 1980, 286:79-80. 10.1038/286079a0, 6993961.
78. Becker SA, Palsson BO. Genome-scale reconstruction of the metabolic network in Staphylococcus aureus N315: an initial draft to the two-dimensional annotation. BMC Microbiol 2005, 5:8. 10.1186/1471-2180-5-8, 1079855, 15752426.
79. Lehar J, Krueger AS, Avery W, Heilbut AM, Johansen LM, Price ER, Rickles RJ, Short GF, Staunton JE, Jin X, et al. Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol 2009, 27:659-666. 10.1038/nbt.1549, 2708317, 19581876.
80. Lehar J, Zimmermann GR, Krueger AS, Molnar RA, Ledell JT, Heilbut AM, Short GF, Giusti LC, Nolan GP, Magid OA, et al. Chemical combination effects predict connectivity in biological systems. Mol Syst Biol 2007, 3:80. 10.1038/msb4100116, 1828746, 17332758.
81. Shi L, Sohaskey CD, Kana BD, Dawes S, North RJ, Mizrahi V, Gennaro ML. Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proc Natl Acad Sci USA 2005, 102:15629-15634. 10.1073/pnas.0507850102, 1255738, 16227431.
82. Wayne LG, Sohaskey CD. Nonreplicating persistence of mycobacterium tuberculosis. Annu Rev Microbiol 2001, 55:139-163. 10.1146/annurev.micro.55.1.139, 11544352.